Barclays shares slump on revenue miss, reduced guidance
By Steve Goldstein
Continuing what's been a difficult week for U.K.-headquartered banks, Barclays shares fell as much as 7% on Thursday as the bank reported revenue below expectations and reduced its margin guidance.
Barclays (BARC.LN) reported a 31% rise in pretax profit of GBP1.96 billion, which topped the GBP1.91 billion consensus estimate after taking fewer impairments than analysts estimated.
Income, however, fell 6% to GBP6.29 billion, below the GBP6.53 billion consensus.
Analysts also highlighted new guidance that U.K. net interest margin for the year will be below 3.2% -- currently estimated to be 3.15%, which the bank attributed to factors including customers holding lower deposit balances and changes in deposit pricing. Customers appear to be using excess deposits to pay down mortgages ahead of their re-fixings, as mortgage rates in the U.K. have surged.
Barclays made clear that it still wants a big presence in corporate and investment banking, which represents 60% of its risk-weighted assets.
"I think I have been pretty clear that when we look strategically at the investment bank, it's been a great success," said CEO C.S. Venkatakrishnan, according to a transcript of the analyst call by S&P Global Market Intelligence. "I also recognized that at approximately 60% to 70% of the bank, it is much more important now to grow the bank that's outside of the investment bank -- and to get a better balance overall."
Within corporate and investment banking, he indicated that Barclays wanted to invest in less-capital intensive areas.
Citigroup analyst Andrew Coombs says the revenue volatility of the fixed income, currency and commodities division and equities division is more than any of its peers in the U.S. or Europe. "While Barclays has made market share gains, notably in FICC, it is hard to reward this when the quarterly volatility is so high, meaning the market puts a lower multiple on these revenue streams," he said.
NatWest shares have slumped 7% over the last five days as its CEO resigned, while Lloyds stock has weakened by 3% as its pretax profit missed analyst estimates.
-Steve Goldstein
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-27-23 0903ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure